Crossmark

Effectiveness and Safety of Liraglutide in Managing Inadequate Weight Loss and Weight Regain after Primary and Revisional Bariatric Surgery: Anthropometric and Cardiometabolic Outcomes

Crossref DOI link: https://doi.org/10.1007/s11695-021-05884-y

Published Online: 2022-01-20

Published Print: 2022-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elhag, Wahiba

El Ansari, Walid https://orcid.org/0000-0003-0961-1302
License Information

Text and Data Mining valid from 2022-01-20

Version of Record valid from 2022-01-20
More Information

Article History

Received: 25 October 2021

Revised: 30 December 2021

Accepted: 30 December 2021

First Online: 20 January 2022

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required. The informed consent was waived (IRB-approved, HIPAA-compliant retrospective study).

: Informed Consent does not apply.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below